Pfizer gene therapy gets hemophilia B approval in Canada, setting stage for CSL rivalry
Pfizer has secured an approval for its gene therapy for hemophilia B in Canada, months ahead of an expected decision in the US.
The …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
